anti-AIV NP antibody product blog
Tags: Antibody; Monoclonal Antibody; AIV NP; anti-AIV NP antibody;
The AIV NP np (Catalog #MBS415046) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s AIV NP can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Western Blot (WB-Re).WB: 1:1000 analysis of Influenza A virus NP with Anti-Influenza A virus NP. Researchers should empirically determine the suitability of the AIV NP np for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The AIV NP np product has the following accession number(s) (GI #73852953) (NCBI Accession #YP_308667). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the Anti-AIV NP Antibody with the following immunoassay(s):
Testing Data
Raised In: Purified mouse monoclonal antibody generated using bacterin as immunogen.
Storage Buffer: citrate-tris-HCl buffer pH7.0 with 0.02% Proclin 300. Immunogen: Bacterin consisting of H5N1 and H9N2. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing AIV NP are readily searchable from our website. Different antibodies against the same target such as AIV NP may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.